Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_113
Snippet: This retrospective, open label, cohort study evaluated IW receiving pimobendan (n = 25; 0.24-0.26 mg/kg PO q12 h); benazepril (n = 24; 0.25-0.5 mg/kg PO q 12 h); methyldigoxin (n = 21; 0.005 mg/kg PO q 12 h); methyldigoxin+benazepril (n = 40); or pimobendan+benazepril (n = 11), for up to 7.8 years. Time to events were estimated by Kaplan Meier method for first onset of CHF, cardiac death, and all-cause mortality using pair-wise comparisons betwee.....
Document: This retrospective, open label, cohort study evaluated IW receiving pimobendan (n = 25; 0.24-0.26 mg/kg PO q12 h); benazepril (n = 24; 0.25-0.5 mg/kg PO q 12 h); methyldigoxin (n = 21; 0.005 mg/kg PO q 12 h); methyldigoxin+benazepril (n = 40); or pimobendan+benazepril (n = 11), for up to 7.8 years. Time to events were estimated by Kaplan Meier method for first onset of CHF, cardiac death, and all-cause mortality using pair-wise comparisons between groups. Pooled data from 86 IW with echocardiographic follow-up were dichotomized based upon improvement in %FS, LV end-systolic, and LV end-diastolic dimensions into references ranges ('responders'), vs. no echo improvement ('nonresponders'), to compare cardiac survival.
Search related documents:
Co phrase search for related documents- cardiac death and cause mortality cardiac death: 1, 2, 3, 4, 5
- cardiac death and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- cardiac death and end diastolic: 1
- cardiac death and event time: 1, 2, 3, 4
- cardiac death and Kaplan Meier method: 1, 2, 3
- cardiac survival and cause mortality: 1, 2, 3, 4, 5, 6
- cardiac survival and cohort study: 1, 2, 3, 4, 5, 6, 7, 8
- cardiac survival and event time: 1
- cause mortality and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- cause mortality and end diastolic: 1, 2, 3
- cause mortality and end systolic: 1
- cause mortality and event time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- cause mortality and Kaplan Meier method: 1, 2, 3, 4, 5, 6, 7
- cause mortality and LV end systolic: 1
- cause mortality and open label: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- cause mortality cardiac death and cohort study: 1
- cohort study and end diastolic: 1, 2, 3, 4, 5, 6
- cohort study and end systolic: 1, 2, 3
- cohort study and event time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
Co phrase search for related documents, hyperlinks ordered by date